Selective androgen receptor modulators activate the canonical prostate cancer androgen receptor program and repress cancer growth
- Michael D. Nyquist
- , Lisa S. Ang
- , Alexandra Corella
- , Ilsa M. Coleman
- , Michael P. Meers
- , Anthony J. Christiani
- , Cordell Pierce
- , Derek H. Janssens
- , Hannah E. Meade
- , Arnab Bose
- , Lauren Brady
- , Timothy Howard
- , Navonil De Sarkar
- , Sander B. Frank
- , Ruth F. Dumpit
- , James T. Dalton
- , Eva Corey
- , Stephen R. Plymate
- , Michael C. Haffner
- , Elahe A. Mostaghel
- Department of Genetics
- Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
- DBBS - Computational and Systems Biology
- DBBS - Developmental, Regenerative and Stem Cell Biology
- DBBS - Molecular Genetics and Genomics
- DBBS - Cancer Biology
- Center of Regenerative Medicine
- Institute of Clinical and Translational Sciences (ICTS)
- Siteman Cancer Center
Research output: Contribution to journal › Article › peer-review
41
Link opens in a new tab
Scopus
citations